News
Stockhead on MSN48m
Health Check: Mayne Pharma shares tumble after suitor threatens to walk over ‘adverse events’Cosette Pharmaceuticals’ $600 million tilt at Mayne Pharma is in peril Analysts back Monash IVF after earnings update EBR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback